-
Open Source ‘Floats All Boats’ in AI-Driven Drug Discovery
Bio-IT World | More than two dozen “grand challenges” remain in small-molecule drug discovery, spanning everything from target selection to developing a medicine that can be safely used in the clinic. No single company can solve all these problems alone, which underscores the importance of computational tools, many of which are built on open-source software.
Mar 17, 2026
-
Ancient Mushroom, Modern Medicine: Paul Stamets Says Agarikon Mycelium May Be Key to Fighting Viral Pandemics
Bio-IT World | Paul Stamets has spent more than four decades in the forests of the Pacific Northwest, carefully prying tissue samples from the undersides of some of the world’s rarest mushrooms. On the stage of February’s Integrative Health Symposium, that lifetime of fieldwork converged with randomized clinical trials and Department of Defense contracts—a collision of ancient ethnobotany and 21st-century immunology that left the audience energized.
Mar 12, 2026
-
Russia to Expand National Genetics Database to Ensure Treatment for Various Ethnic Groups
Bio-IT World | Russia is significantly expanding the existing national database of genetic variant frequencies of the domestic population in a move to improve treatment of some socially important diseases and reduce the mortality rate from them.
Mar 11, 2026
-
How HPC Systems Are Making Things Easier
Bio-IT World | In the newest episode of Trends from the Trenches, guest host Jessica StLouis, senior scientific consultant at BioTeam, speaks with Jarett DeAngelis, director of scientific computing, and Shane Corder, senior HPC engineer, both at the Moffitt Cancer Center. Their conversation centers on how Moffitt is redesigning HPC infrastructure to reduce friction in research collaboration, streamline data sharing, and expand access to advanced computational resources.
Mar 10, 2026


